No Data
Lu Chongmao: The "1+" mechanism has approved a total of 5 new drug applications, with the cost of 2 drugs decreasing by nearly 30%.
Dr. Constance Chan, Director of Health, stated at the Legislative Council meeting today (8th) that since the new drug approval mechanism ("1+1" mechanism) took effect, the Department of Health has received inquiries from more than 80 pharmaceutical companies, totaling over 260, and has approved a total of 5 new drug applications. These include 2 treatments for metastatic colorectal cancer, 1 treatment for paroxysmal nocturnal hemoglobinuria, 2 treatments for patients with parathyroid cancer and a certain type of hypercalcemia in patients with primary hyperparathyroidism. Dr. Constance Chan revealed that two of the new drugs for the treatment of metastatic colorectal cancer have been included in the public hospital authority's list of specialty drugs. The public hospital authority has also successfully completed procurement discussions.
Hong Kong stocks have seen unusual movements, with CRO concept stocks generally under pressure. The emotions are influenced by the results of the USA election. Institutions point out that the probability of the Biosecurity Law being an independent law may
CRO concept stocks are generally under pressure. As of the time of publication, GenScript Biotech (01548) fell by 6.68% to HKD 10.9; Viva Biotech (01873) fell by 3.16% to HKD 0.92; Pharmaron (03759) fell by 2.64% to HKD 16.22.
Hong Kong stock concept tracking | Peking expands the reimbursement scope of hematopoietic stem cell transplantation medical insurance. Stem cell-related pharmaceutical companies benefit (concept stocks)
Peking Medical Insurance Bureau: Expand the scope of reimbursement for hematopoietic stem cell transplantation under medical insurance.
Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident That China's High-Level Openness Is a Historical Opportunity
Shanghai Fosun Pharma Announces Drug Registration Acceptance
fosun pharma (02196): The drug registration applications for Levofloxacin Injection and Azacitidine Injection have been accepted by the National Medical Products Administration.
fosun pharma (02196) announced that fosun pharma (group) co., ltd. (hereinafter referred to as the "company"...
No Data
No Data